NEUROPACE, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NEUROPACE, INC. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $2.83M.
- NEUROPACE, INC. stock issued during period, value, new issues for the quarter ending 2021-06-30 was $105.49M.
- NEUROPACE, INC. stock issued during period, value, new issues for fiscal 2024 was $3.17M, a 58.45% decline from fiscal 2023.
- NEUROPACE, INC. stock issued during period, value, new issues for fiscal 2023 was $7.62M.
- NEUROPACE, INC. stock issued during period, value, new issues for fiscal 2021 was $105.49M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-12-31 | $3.17M 10-K · filed 2025-03-04 | |
| 2024-09-30 | $2.83M 10-Q · filed 2024-11-12 | |
| 2023-12-31 | $7.62M 10-K · filed 2025-03-04 | |
| 2021-12-31 | $105.49M 10-K · filed 2023-03-02 | |
| 2021-06-30 | $105.49M 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |